In a cohort with 393 Korean patients with HCC, mostly with underlying chronic viral hepatitis B, the IGF-CTP classification system showed no statistically significant improvement of stratification but demonstrated a trend towards better prediction of survival. This evidence concerns the gene IGF1 and hepatocellular carcinoma.